PsA Diagnostic Test Grant
NPF’s primary research goal is to lead collaborative, transformational research in psoriatic disease. As part of this goal, NFP introduced a new grant mechanism in 2019: The PsA Diagnostic Test Grant. This grant program, which aims to fund the development of a clinically applicable diagnostic test for psoriatic arthritis, has funded first-year, proof-of-concept proposals that have the potential to achieve our goal within five years. This research is continuing.
Psoriasis Prevention Initiative
Additionally, the National Psoriasis Foundation’s Psoriasis Prevention Initiative (PPI) aims to identify an intervention that will prevent the onset of psoriatic disease, disease relapse or relevant comorbidities, utilizing a multi-institution, multi-disciplinary, team-based research network. This research network will collaborate to address how to overcome the burden of psoriatic disease on patient's lives through prevention of disease.
Another avenue of NPF research is patient-centered research. In addition to Citizen Pscientist, where more than 5,400 patients share data, trends, and questions, NPF also conducts its Annual Survey. In 2019, the survey saw an almost seven-fold increase in response rates compared to previous years. As of early 2020, NPF has submitted four abstracts from survey findings and two have already been accepted; they are under review. The 2020 Society for Investigative Dermatology Annual Meeting accepted the two abstracts, which were written in collaboration with Joseph Merola, M.D., and Alice Gottlieb, M.D., Ph.D.